China Biologic Products set to make clotting aid post CFDA inspection
China Biologic Products is set to become the second Chinese producer of a prothrombin complex concentrate (PCC) blood clotting product following an inspection by the CFDA
Archives for August 11, 2014
Institutional investors decry US battle over biosimilars
As Celltrion announced Monday that it filed the first monoclonal antibody for approval with the US FDA, investor groups are crying foul over some of the tactics used by others in industry to discourage the uptake of biosimilars in the US.
Biopharma companies race to develop Ebola vaccine
As the death toll from the world’s most expansive Ebola outbreak nears 1,000, multiple companies are stepping up efforts to bring antibodies and other vaccines to human trials, though none seem likely to be ready until 2015 at the earliest.